Nurix Therapeutics (NRIX) Shares Outstanding (Entity) (2019 - 2026)
Nurix Therapeutics (NRIX) reported Shares Outstanding (Entity) of 103.7 million for fiscal Q2 2026 (quarter ended May 31, 2026), up 35.7% from 76.43 million a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
For FY2025 (ended Nov 30, 2025), Nurix Therapeutics posted Shares Outstanding (Entity) of 101.81 million, up 34.2% from FY2024.
- Shares Outstanding (Entity) has increased for six consecutive fiscal years, with a five-year compound annual growth rate of 45.4% (FY2020 to FY2025).
- By fiscal year, Shares Outstanding (Entity) came in at 75.87 million in FY2024 (+55.7%), 48.72 million in FY2023 (+3.3%), 47.17 million in FY2022 (+5.6%) and 44.66 million in FY2021 (+185.0%).
- The fiscal Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q3 2019.
- Year over year, Shares Outstanding (Entity) has now increased in each of the last 20 quarters, with growth averaging 36.0% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 1.4% (fiscal Q2 2022) and 185.0% (fiscal Q4 2021) over the last five years.
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at 103.4 million (Q1 2026), 101.81 million (Q4 2025) and 76.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Nurix Therapeutics | 2.45 Bn | 448.58 Mn | - | 103.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 103.70 Mn |
| Feb 28, 2026 | 103.40 Mn |
| Nov 30, 2025 | 101.81 Mn |
| Aug 31, 2025 | 76.87 Mn |
| May 31, 2025 | 76.43 Mn |
| Feb 28, 2025 | 76.23 Mn |
| Nov 30, 2024 | 75.87 Mn |
| Aug 31, 2024 | 67.08 Mn |
| May 31, 2024 | 64.36 Mn |
| Feb 29, 2024 | 49.14 Mn |
| Nov 30, 2023 | 48.72 Mn |
| Aug 31, 2023 | 48.50 Mn |
| May 31, 2023 | 47.63 Mn |
| Feb 28, 2023 | 47.44 Mn |
| Nov 30, 2022 | 47.17 Mn |
| Aug 31, 2022 | 47.15 Mn |
| May 31, 2022 | 45.04 Mn |
| Feb 28, 2022 | 44.85 Mn |
| Nov 30, 2021 | 44.66 Mn |
| Aug 31, 2021 | 44.56 Mn |
API Access
Nurix Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();